Pfizer has administered its first COVID-19 booster shots. The pharmaceutical company is studying a third dose of the vaccine and a pneumococcal vaccine candidate. The first participants received their shots Monday.
We’re learning new information about Pfizer and Moderna’s vaccines, plus variants and boosters.
Federal health advisers have endorsed use of Pfizer’s COVID-19 vaccine in kids as young as 12.
The FDA is expanding the emergency use authorization for the Pfizer vaccine for kids ages 12-15. CDC leaders plan to meet later this week to discuss distribution, and kids could start getting shots in arms as early as this week once the CDC director signs the agency’s recommendations.
The U.S. is expanding use of Pfizer’s COVID-19 vaccine to children as young as 12. The Food and Drug Administration said Monday the shot is safe and offers strong protection for younger teens based on testing of more than 2,000 U.S. volunteers.
This week, the Food and Drug Administration is expected to grant emergency use authorization of Pfizer’s COVID-19 vaccine for kids between 12-15 years old.
Canada’s health regulator has authorized Pfizer’s COVID-19 vaccine for ages 12 and older.
The U.S. Food and Drug Administration is expected to authorize Pfizer’s COVID-19 vaccine for kids ages 12 to 15 by next week, setting up shots for many before the beginning of the next school year.
A new study suggests COVID-19 vaccines from Pfizer and Moderna do not appear to pose serious risk during pregnancy. Researchers reviewed data from more than 35,000 pregnant women from December of last year through February of this year.
Governor Henry McMaster has received his first coronavirus shot. Monday, the governor released on social media that he and First Lady Peggy McMaster visited CVS Pharmacy in Columbia to receive their first dose of the Pfizer vaccine.
